Overview

Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma

Status:
Completed

Trial end date:
2011-08-26

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the efficacy and safety of vilanterol inhalation powder administered once daily in the evening in adolescent and adult subjects 12 years of age and older with persistent asthma over a 12-week treatment period.

Phase:

Phase 3

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Salmeterol Xinafoate